Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis

Table 2 Univariate and multivariate analysis to determine predictive factors for complete recanalization

Variables	HR	95% CI	P value	HR	95% CI	P value
Male	0.918	0.478–1.764	0.798
Age (years)	1.015	0.992–1.039	0.197
Esophageal varices	0.501	0.258–0.973	0.041	1.730	0.873–3.429	0.116
NOACs	1.084	0.578–2.031	0.801
Child–Pugh score	0.930	0.703–1.232	0.614
MELD score	0.967	0.891–1.05	0.426
Total bilirubin (umol/L)	0.996	0.978–1.014	0.667
Albumin (g/L)	1.033	0.970–1.099	0.310
GFR (mL/ min)	0.991	0.977–1.006	0.230
INR	0.328	0.068–1.584	0.165
D-dimer (ug/mL)	1.188	1.058–1.334	0.004	1.165	1.036–1.311	0.011
Platelet (x10^9/L)	1.001	0.999–1.004	0.322
Yerdel classification	1.006	0.777–1.302	0.962
Complete occlusive thrombus	1.022	0.504–2.074	0.952

HR Hazard ratio, CI Confidence interval, NOACs New oral anticoagulants, MELD score Model for End-Stage Liver Disease, INR International normalized ratio, GFR Glomerular filtration rate

ISSN: 1471-230X